Rehovot, Israel

Nataly Urshanski


Average Co-Inventor Count = 4.0

ph-index = 1

Forward Citations = 4(Granted Patents)


Company Filing History:


Years Active: 2017

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Nataly Urshanski: Innovator in Neuroinflammatory Disease Treatment

Introduction

Nataly Urshanski is a prominent inventor based in Rehovot, Israel. She has made significant contributions to the field of neuroinflammatory and neurodegenerative diseases through her innovative research and patenting efforts. Her work focuses on developing pharmaceutical compositions that can effectively treat these challenging conditions.

Latest Patents

Nataly holds a patent titled "Use of blocking agents of bone morphogenic protein (BMP) signalling for the treatment of neuroinflammatory and neurodegenerative diseases." This invention provides pharmaceutical compositions that comprise a single or a combination of several blocking agents of Bone Morphogenic Protein (BMP) signaling. The patent outlines methods for treating neuroinflammatory or neurodegenerative diseases by administering these compositions to patients in need.

Career Highlights

Nataly is associated with the Medical Research, Infrastructure and Health Services Fund of the Tel Aviv Medical Center. Her role in this organization allows her to contribute to groundbreaking research aimed at improving health outcomes for patients suffering from neuroinflammatory conditions.

Collaborations

Nataly has collaborated with notable colleagues, including Arnon Karni and Yifat Amir Levi. These partnerships enhance her research efforts and contribute to the advancement of knowledge in her field.

Conclusion

Nataly Urshanski's innovative work in the treatment of neuroinflammatory and neurodegenerative diseases showcases her dedication to improving patient care through scientific research. Her contributions are paving the way for new therapeutic approaches in medicine.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…